HUP0400799A2 - Fedett ízű gyógyszerészeti készítmény és eljárás előállítására - Google Patents

Fedett ízű gyógyszerészeti készítmény és eljárás előállítására

Info

Publication number
HUP0400799A2
HUP0400799A2 HU0400799A HUP0400799A HUP0400799A2 HU P0400799 A2 HUP0400799 A2 HU P0400799A2 HU 0400799 A HU0400799 A HU 0400799A HU P0400799 A HUP0400799 A HU P0400799A HU P0400799 A2 HUP0400799 A2 HU P0400799A2
Authority
HU
Hungary
Prior art keywords
taste
preparation
mixture
masking
production
Prior art date
Application number
HU0400799A
Other languages
English (en)
Inventor
Philippe Becourt
Josiane Chauvin
Detlev Schwabe
Original Assignee
Aventis Pharma S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma S.A. filed Critical Aventis Pharma S.A.
Publication of HUP0400799A2 publication Critical patent/HUP0400799A2/hu
Publication of HUP0400799A3 publication Critical patent/HUP0400799A3/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Abstract

A találmány tárgya fedett ízű gyógyszerészeti készítmény, különösenvizes vivőanyaggal alkotott szuszpenzió formájában, amelynek ízfedésea készítmény adagolása során megmarad, amelyre jellemző, hogy legalábbaz alábbi komponenseket tartalmazza: a) szerves oldószerekben oldható,de vízben bármely pH-nál gyakorlatilag oldhatatlan cellulóz polimer;savas közegben oldható és semleges vagy lúgos pH-nál gyakorlatilagoldhatatlan metakril polimer és egy hatóanyag, amely a keverékbenhomogén módon és molekuláris állapotban van elosztva, ahol a keverékatomizált mátrix formában van; b) gyógyszerészetileg alkalmazhatószerves jellegű lúgos szer vagy alkálifémsó; c) adszorbeálószer. Atalálmány a készítmény előállítására szolgáló eljárásra és egy agyógyszerészeti hatóanyagok ízének elfedésére szolgáló eljárásra isvonatkozik. Ó
HU0400799A 2001-06-21 2002-06-21 Pharmaceutical formulation having a masked taste and method for the production thereof HUP0400799A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0108157A FR2826274B1 (fr) 2001-06-21 2001-06-21 Formulation pharmaceutique au gout masque et son procede de preparation
PCT/FR2002/002158 WO2003000225A2 (fr) 2001-06-21 2002-06-21 Formulation pharmaceutique au gout masque et son procede de preparation

Publications (2)

Publication Number Publication Date
HUP0400799A2 true HUP0400799A2 (hu) 2004-08-30
HUP0400799A3 HUP0400799A3 (en) 2012-08-28

Family

ID=8864587

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0400799A HUP0400799A3 (en) 2001-06-21 2002-06-21 Pharmaceutical formulation having a masked taste and method for the production thereof

Country Status (42)

Country Link
US (2) US7138138B2 (hu)
EP (1) EP1401397B1 (hu)
JP (1) JP4880871B2 (hu)
CN (1) CN1239149C (hu)
AP (1) AP1595A (hu)
AR (1) AR036096A1 (hu)
AT (1) ATE290366T1 (hu)
AU (1) AU2002329311B2 (hu)
BG (1) BG66314B1 (hu)
BR (1) BRPI0208998A2 (hu)
CA (1) CA2452239C (hu)
CO (1) CO5540278A2 (hu)
CZ (1) CZ299947B6 (hu)
DE (1) DE60203178T2 (hu)
EA (1) EA006016B1 (hu)
EC (1) ECSP034915A (hu)
ES (1) ES2236574T3 (hu)
FR (1) FR2826274B1 (hu)
GT (2) GT200200115AA (hu)
HK (1) HK1067558A1 (hu)
HR (1) HRP20031067B1 (hu)
HU (1) HUP0400799A3 (hu)
IL (2) IL159404A0 (hu)
JO (1) JO2325B1 (hu)
MA (1) MA27042A1 (hu)
MX (1) MXPA03011756A (hu)
MY (1) MY134340A (hu)
NO (1) NO332258B1 (hu)
NZ (1) NZ530042A (hu)
OA (1) OA12635A (hu)
PA (1) PA8548301A1 (hu)
PE (1) PE20030201A1 (hu)
PL (1) PL202090B1 (hu)
PT (1) PT1401397E (hu)
SK (1) SK285865B6 (hu)
SV (1) SV2003001098A (hu)
TN (1) TNSN03141A1 (hu)
TW (1) TWI228049B (hu)
UA (1) UA77960C2 (hu)
UY (1) UY27341A1 (hu)
WO (1) WO2003000225A2 (hu)
ZA (1) ZA200309479B (hu)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7384921B2 (en) * 2004-02-20 2008-06-10 Enanta Pharmaceuticals, Inc. Polymorphic forms of 6-11 bicyclic ketolide derivatives
GB2419094A (en) 2004-10-12 2006-04-19 Sandoz Ag Pharmaceutical composition of unpleasnt tasing active substances
FR2882522B1 (fr) 2005-02-25 2007-04-13 Aventis Pharma Sa Composition pharmaceutique solide comprenant de la telithromycine
US7384922B2 (en) * 2005-05-04 2008-06-10 Enanta Pharmaceuticals, Inc. 6-11 bridged oxime erythromycin derivatives
US20060264386A1 (en) * 2005-05-17 2006-11-23 Rongqi Sun Pharmaceutical formulations of 6-11 bicyclic ketolide derivatives and related macrolides and methods for preparation thereof
CA2641351C (en) * 2006-02-03 2014-05-06 Christian Meier Pharmaceutical compositions containing mixtures of polymers and active agents poorly soluble in water
WO2007108010A2 (en) * 2006-03-21 2007-09-27 Jubilant Organosys Limited Taste masked pharmaceutical composition for oral solid dosage form and process for preparing the same using magnesium aluminium silicate
WO2008094877A2 (en) * 2007-01-30 2008-08-07 Drugtech Corporation Compositions for oral delivery of pharmaceuticals
KR100935893B1 (ko) * 2007-09-11 2010-01-07 국방과학연구소 1,1'-다이메틸-5,5’-바이테트라졸의 합성방법
EP2214484A4 (en) 2007-10-25 2013-01-02 Cempra Pharmaceuticals Inc PROCESS FOR PREPARING ANTIBACTERIAL MAKROLIDE AGENTS
NZ593559A (en) 2008-12-16 2013-05-31 Carlsberg As Coating of hydroxylated surfaces by gas phase grafting
CN104470527B (zh) 2012-03-27 2019-05-28 森普拉制药公司 用于施用大环内酯抗生素的肠胃外制剂
DE102012014848A1 (de) * 2012-07-27 2012-10-31 Heilerde-Gesellschaft Luvos Just GmbH & Co. KG Heilerde-Zubereitung
AU2015301154A1 (en) * 2014-08-05 2017-02-23 Cempra Pharmaceuticals, Inc. Powder oral suspension formulations of antibacterial agents
CN114209661B (zh) * 2022-02-21 2022-04-29 北京罗诺强施医药技术研发中心有限公司 呈细粒形式的固体药物组合物

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2930409A1 (de) * 1979-07-26 1981-02-12 Bayer Ag Spruehtrocknung von mikrokapseldispersionen
JPS63150220A (ja) * 1986-12-15 1988-06-22 Dainippon Pharmaceut Co Ltd 経口用固形製剤の製造方法
US4808411A (en) * 1987-06-05 1989-02-28 Abbott Laboratories Antibiotic-polymer compositions
US5084278A (en) * 1989-06-02 1992-01-28 Nortec Development Associates, Inc. Taste-masked pharmaceutical compositions
ZA945944B (en) * 1993-08-13 1996-02-08 Eurand America Inc Procedure for encapsulating nsaids
AUPN969796A0 (en) * 1996-05-07 1996-05-30 F.H. Faulding & Co. Limited Taste masked liquid suspensions
AU9182498A (en) * 1997-10-03 1999-04-27 Elan Corporation, Plc Taste masked formulations
IN191239B (hu) * 1999-06-11 2003-10-11 Ranbaxy Lab Ltd
US6555569B2 (en) * 2000-03-07 2003-04-29 Pfizer Inc. Use of heteroaryl substituted N-(indole-2-carbonyl-) amides for treatment of infection
AU2001282105A1 (en) * 2000-08-22 2002-03-04 Basilea Pharmaceutica Ag New macrolides with antibacterial activity

Also Published As

Publication number Publication date
UY27341A1 (es) 2003-01-31
HK1067558A1 (en) 2005-04-15
JO2325B1 (en) 2006-06-28
CN1239149C (zh) 2006-02-01
BG66314B1 (bg) 2013-04-30
SK15922003A3 (sk) 2004-05-04
HRP20031067B1 (en) 2011-10-31
IL159404A (en) 2007-08-19
DE60203178D1 (de) 2005-04-14
US20070014857A1 (en) 2007-01-18
TNSN03141A1 (fr) 2005-12-23
CZ299947B6 (cs) 2009-01-07
UA77960C2 (en) 2007-02-15
SV2003001098A (es) 2003-03-18
CO5540278A2 (es) 2005-07-29
EP1401397B1 (fr) 2005-03-09
AR036096A1 (es) 2004-08-11
PE20030201A1 (es) 2003-03-12
ES2236574T3 (es) 2005-07-16
IL159404A0 (en) 2004-06-01
NO332258B1 (no) 2012-08-13
ATE290366T1 (de) 2005-03-15
WO2003000225A2 (fr) 2003-01-03
EP1401397A2 (fr) 2004-03-31
JP4880871B2 (ja) 2012-02-22
EA006016B1 (ru) 2005-08-25
PL202090B1 (pl) 2009-06-30
ZA200309479B (en) 2005-04-26
JP2004534810A (ja) 2004-11-18
CA2452239C (fr) 2011-07-19
SK285865B6 (sk) 2007-10-04
DE60203178T2 (de) 2006-01-26
MA27042A1 (fr) 2004-12-20
MY134340A (en) 2007-12-31
EA200400061A1 (ru) 2004-06-24
GT200200115A (es) 2003-02-27
PA8548301A1 (es) 2003-09-05
BRPI0208998A2 (pt) 2017-06-06
BG108458A (bg) 2005-02-28
ECSP034915A (es) 2004-02-26
HRP20031067A2 (en) 2004-04-30
GT200200115AA (es) 2005-01-12
FR2826274A1 (fr) 2002-12-27
AP1595A (en) 2006-04-12
NO20035581D0 (no) 2003-12-15
US20040142029A1 (en) 2004-07-22
PT1401397E (pt) 2005-05-31
AU2002329311B2 (en) 2007-02-01
NZ530042A (en) 2005-09-30
CN1529585A (zh) 2004-09-15
OA12635A (fr) 2006-06-15
HUP0400799A3 (en) 2012-08-28
CA2452239A1 (fr) 2003-01-03
FR2826274B1 (fr) 2003-09-26
AP2003002927A0 (en) 2003-12-31
PL366803A1 (en) 2005-02-07
CZ20033441A3 (en) 2004-03-17
MXPA03011756A (es) 2004-07-01
TWI228049B (en) 2005-02-21
WO2003000225A3 (fr) 2003-03-13
US7138138B2 (en) 2006-11-21

Similar Documents

Publication Publication Date Title
HUP0400799A2 (hu) Fedett ízű gyógyszerészeti készítmény és eljárás előállítására
AU2001239658A1 (en) Method for producing a controlled-release preparation
WO2002085951A3 (en) Water soluble, randomly substituted partial n-, partial o-acetylated chitosan, preserving compositions containing chitosan, and processes for making thereof
BR0211028A (pt) Solução aquosa, método para formação de associações de fármaco e polìmero, composições farmacêuticas, método para formação de uma composição farmacêutica e produto
KR950702409A (ko) 방출 조절 모르핀 제제(controlled release morphine preparation)
CA2445276A1 (en) Aripiprazole oral solution
CA2336570A1 (en) Croscarmellose taste masking
CA2003190A1 (en) Pharmaceutical compositions containing n-(3,4-dimethoxycinnamoyl) anthranilic acid
HUP0401569A2 (hu) Amlodipint és atorvastatint tartalmazó gyógyászati készítmények és eljárás az előállításukra
BR9607189A (pt) Formas de dosagem oral contendo um antibiótico de b-lactama
HUP0300953A2 (hu) Kinolon antibiotikum-tartalmú, késleltetett kioldású, orálisan adagolható készítmény és eljárás ennek előállítására
UA89349C2 (uk) Таблетка без покриття, яка містить оланзапін, та спосіб її одержання
CA2388325A1 (en) Ciclesonide-containing aqueous pharmaceutical composition
JP2711528B2 (ja) ロキソプロフェン製剤
JP3658878B2 (ja) 内服液剤
NO307933B1 (no) Vann-uløselig eller lite vannløselig terapeutisk forbindelse, anvendelse derav samt farmasøytisk blanding inneholdende nevnte forbindelse
JP4969747B2 (ja) 錠剤フィルムコーティング用組成物
JP2007001873A (ja) コーティング組成物及びコーティングされた固形製剤
WO2004093827A3 (en) Phenolic acid salts of gabapentin in solid dosage forms and methods of use
WO2000025765A3 (de) Wässrige arzneimittelformulierung zur oralen applikation
KR970703156A (ko) 고형 제산제 및 이의 제조방법(Solid antacid and process for producing the same)
ATE380018T1 (de) Verfahren zur herstellung von wirkstoffhaltigen pellets
AU2002366724A1 (en) Stable granulates containing s-adenosylmethionne and process for the preparation thereof
GR1004331B (el) Νεες φαρμακευτικες συνθεσεις που περιεχουν αλας αλενδρονικου οξεος
TH58760B (th) สูตรผสมทางเภสัชกรรมที่มีรสที่ถูกปิดบังแล้ว และกรรมวิธีสำหรับการเตรียมของมัน

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees